Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases
חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1
מצבים רפואיים
Unresectable Pancreatic Cancer · Advanced Pancreatic Cancer · Lymph Node Metastases
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Henan Cancer Hospital, Zhengzhou, Henan, China
Contact: Study coordinator (Suxia Luo)Contact: Principal Investigator (Suxia Luo)Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Contact: Study coordinator (Duanmin Hu)Contact: Principal Investigator (Duanmin Hu)Shanghai Changhai Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Zhaoshen Li)Contact: Study coordinator (Yiqi Du)Contact: Principal Investigator (Zhaoshen Li)Contact: Principal Investigator (Yiqi Du)Shanghai General Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Qi Li)Contact: Study coordinator (Xueying Ding)Contact: Principal Investigator (Qi Li)Contact: Principal Investigator (Xueying Ding)Chongqing University Cancer Hospital, Chongqing, China
Contact: Study coordinator (Weiqing Chen)Contact: Principal Investigator (Weiqing Chen)Tianjin Medical University General Hospital, Tianjin, China
Contact: Study coordinator (Bangmao Wang)Contact: Principal Investigator (Bangmao Wang)
מובילי המחקר
Zhaoshen Li
Principal Investigator
Changhai Hospital